Stay tuned and follow the latest developments and news in Molecular Oncology.
Athens, Greece – July 2026
Genekor Medical SA, a leading multinational provider of molecular diagnostics and precision medicine solutions based in Greece, is announcing a new partnership with Molecular Medicine Research Center PRIMAX LLC, a licensed medical research and diagnostics center based in Tbilisi, Georgia.
Under this collaboration, both companies will leverage their scientific competencies to enhance early diagnosis, provide the tools for personalized treatment, and promote more efficient and cost-effective healthcare solutions to patients in need in the region.
Moreover, the alliance will focus on several key areas in oncology and beyond, including:
• Molecular response to treatment
• Determination of hereditary syndromes
• Early Cancer Detection
• Pharmacogenomics
• Scientific support and genetic counseling
“This partnership with PRIMAX represents an important step in Genekor Medical’s international expansion and in our mission to make advanced precision diagnostics accessible to more patients and physicians across Europe and Asia. By combining Genekor’s deep expertise in molecular diagnostics and precision oncology with PRIMAX’s strong regional presence, we are creating a powerful platform to bring clinically meaningful innovation closer to the patients who need it. We see this as the beginning of a long-term strategic partnership, founded on scientific excellence, mutual trust, and a shared ambition to advance the standard of precision medicine across the region”
Dr Nikolaos Tsoulos, CEO, Genekor Medical SA
Genekor Medical SA is a Greek based multinational molecular diagnostics company specializing in genetic testing and precision medicine, supporting physicians and patients with advanced diagnostic solutions across oncology, hereditary disease risk, and pharmacogenomics.
Molecular Medicine Research Center – PRIMAX LLC is an accredited, Georgia-based molecular diagnostics company specializing in hematologic malignancies, oncogenetics, and precision medicine. PRIMAX supports physicians and patients with advanced diagnostic solutions and personalized counseling across oncology, hematopathology, rare disorders, and transplant immunogenetics.